Financials in USD. Standardized financial statements.
A compact view of how STRATA Skin Sciences, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $30.70M | $33.56M | $33.36M | $36.16M | $29.98M | $23.09M | $31.59M | $29.86M | $31.45M | $31.76M |
| Revenue Growth? | -8.5% | +0.6% | -7.8% | +20.6% | +29.8% | -26.9% | +5.8% | -5.1% | -1.0% | 0.0% |
| Cost of Revenue? | $12.81M | $14.48M | $14.90M | $14.39M | $10.13M | $8.96M | $11.32M | $12.73M | $13.50M | $12.64M |
| Gross Profit? | $17.88M | $19.08M | $18.46M | $21.77M | $19.85M | $14.13M | $20.27M | $17.12M | $17.95M | $19.12M |
| Gross Margin? | +58.3% | +56.9% | +55.3% | +60.2% | +66.2% | +61.2% | +64.2% | +57.3% | +57.1% | +60.2% |
| Operating Expenses? | $23.72M | $28.34M | $27.07M | $26.42M | $24.25M | $18.21M | $23.28M | $20.48M | $20.36M | $22.72M |
| Operating Income? | -$5.83M | -$9.26M | -$8.60M | -$4.65M | -$4.40M | -$4.08M | -$3.01M | -$3.35M | -$2.41M | -$3.60M |
| EBITDA? | -$1.37M | -$2.84M | -$3.38M | $1.13M | $1.73M | -$15,000 | $1.81M | $2.04M | $4.54M | $2.77M |
| Income Before Tax | -$6.25M | -$10.26M | -$10.92M | -$5.49M | -$2.67M | -$4.14M | -$3.94M | -$4.30M | -$18.70M | -$3.08M |
| Income Tax Expense | $12,000 | -$170,000 | -$92,000 | $63,000 | $34,000 | $275,000 | -$149,000 | -$264,000 | $129,000 | $255,000 |
| Net Income? | -$6.26M | -$10.09M | -$10.83M | -$5.55M | -$2.71M | -$4.41M | -$3.79M | -$4.03M | -$21.51M | -$3.33M |
| EPS? | $-1.35 | $-0.26 | $-0.31 | $-0.16 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-3.26 | $-3.77 |
| Diluted EPS? | $-1.35 | $-0.26 | $-0.31 | $-0.16 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-3.26 | $-1.44 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality